Global Electric Skin Patch Market Outlook, 2029

The electric skin patch market has witnessed significant growth over the past few years, driven by advancements in technology, increasing healthcare expenditure, and rising demand for non-invasive and portable medical devices. The market has a rich history that dates back to the early 2000s when the first electric skin patch was developed to deliver pain relief through transcutaneous electrical nerve stimulation (TENS). Since then, the market has evolved significantly, with several companies introducing innovative electric skin patches for various medical applications, including pain management, wound healing, and drug delivery. The electric skin patch market has gained widespread acceptance due to its ability to provide non-invasive and convenient treatment options for various medical conditions. The market has also been influenced by the growing trend of self-care and personalized medicine, with consumers increasingly seeking ways to take control of their health and wellness. This has led to the development of electric skin patches that can be used in the comfort of one's home, without the need for a prescription or medical supervision. The competitive landscape of the electric skin patch market is characterized by the presence of several large and small players, including Procter & Gamble, Galvani Bioelectronics, LEO Pharma, and NeuroMetrix. These companies are investing heavily in research and development to introduce new and improved electric skin patches that can address a wide range of medical conditions. They are also focusing on strategic partnerships and collaborations to expand their market presence and enhance their product offerings. Government rules and regulations play a crucial role in shaping the electric skin patch market. In the United States, the Food and Drug Administration (FDA) regulates electric skin patches as medical devices, requiring companies to obtain premarket approval before marketing their products. Similarly, in the European Union, electric skin patches are classified as medical devices and must comply with the Medical Devices Regulation (MDR). These regulations ensure that electric skin patches are safe and effective for their intended use, while also promoting innovation and competition in the market. According to the research report, “Global Electric Skin Patch Market Outlook, 2029” published by Bonafide Research, the market is expected to grow with 12.40% CAGR by 2024-29.The electric skin patch market is its potential to revolutionize drug delivery. Electric skin patches can be used to deliver drugs through the skin, bypassing the gastrointestinal tract and reducing the risk of side effects. This has led to the development of electric skin patches for conditions such as diabetes, migraine, and nausea. The market is also exploring the use of electric skin patches for the delivery of vaccines, which could have significant implications for global health. Strategies adopted by players in the electric skin patch market include product innovation, strategic partnerships, and geographic expansion. Product innovation is a key strategy, with companies investing in research and development to introduce new and improved electric skin patches that can address a wide range of medical conditions. Strategic partnerships are also important, with companies collaborating with other players in the healthcare industry to expand their market presence and enhance their product offerings. Geographic expansion is another key strategy, with companies seeking to enter new markets and expand their customer base. The electric skin patch market include technological advancements, increasing healthcare expenditure, and rising demand for non-invasive and portable medical devices. Technological advancements are enabling the development of smaller, more comfortable, and more effective electric skin patches. Increasing healthcare expenditure is driving demand for electric skin patches, as consumers seek ways to manage their health and wellness. Rising demand for non-invasive and portable medical devices is also contributing to the growth of the market, as electric skin patches offer a convenient and non-invasive treatment option.

Market Drivers • Technological Advancements: One of the primary drivers of the electric skin patch market is technological advancements. The development of new materials, miniaturization of electronic components, and improvements in battery technology have enabled the creation of smaller, more comfortable, and more effective electric skin patches. These patches can now be designed to deliver precise doses of medication, monitor vital signs, and even communicate with smartphones and other devices. The integration of sensors and wireless connectivity in electric skin patches has also opened up new possibilities for remote patient monitoring and telemedicine. Patients can now use electric skin patches to track their health data in real-time and share this information with their healthcare providers, enabling more personalized and effective treatment plans. The use of artificial intelligence (AI) and machine learning (ML) in electric skin patches is expected to further enhance their capabilities. AI and ML algorithms can analyze patient data to identify patterns and predict health outcomes, enabling early intervention and prevention of adverse events. • Increasing Prevalence of Chronic Diseases: The electric skin patch market is the increasing prevalence of chronic diseases, such as diabetes, cardiovascular disease, and chronic pain. According to the World Health Organization (WHO), chronic diseases are the leading cause of death and disability worldwide. Electric skin patches offer a non-invasive and convenient treatment option for patients with chronic diseases. For example, electric skin patches can be used to deliver insulin to patients with diabetes, reducing the need for injections and improving compliance. Similarly, electric skin patches can be used to manage chronic pain, reducing the need for opioids and other addictive pain medications. Market Trends

Make this report your own

Have queries/questions regarding a report?

Take advantage of intelligence tailored to your business objective

Ask an Expert

Manmayi Raval

Research Consultant

• Personalized Medicine: The electric skin patch market is the move towards personalized medicine. Personalized medicine involves tailoring medical treatment to the individual characteristics of each patient, based on their genetic makeup, lifestyle, and other factors.Electric skin patches offer a unique opportunity for personalized medicine, as they can be designed to deliver precise doses of medication based on the patient's specific needs. For example, a patient with high blood pressure may require a different dose of medication than a patient with low blood pressure. Electric skin patches can be programmed to deliver the appropriate dose of medication based on the patient's specific condition. Electric skin patches can be used to monitor the patient's response to treatment and adjust the dosage accordingly. This can improve the effectiveness of treatment and reduce the risk of adverse events. • Wearable Health Technology: The electric skin patch market is the growing popularity of wearable health technology. Wearable devices, such as fitness trackers and smartwatches, have become increasingly popular in recent years, as consumers seek ways to monitor their health and wellness. Electric skin patches fit into this trend, as they offer a non-invasive and convenient way to monitor health data. For example, electric skin patches can be used to monitor heart rate, blood pressure, and other vital signs, providing real-time feedback to the patient and their healthcare provider. Electric skin patches can be integrated with other wearable devices, such as smartphones and smartwatches, to provide a more comprehensive view of the patient's health. This can enable more personalized and effective treatment plans, as healthcare providers can use the data from multiple devices to make informed decisions about the patient's care. Market Challenges • Regulatory Hurdles: The electric skin patch market is the regulatory hurdles associated with bringing new products to market. Electric skin patches are classified as medical devices, which means they must undergo rigorous testing and approval processes before they can be sold to consumers. The regulatory requirements for electric skin patches vary by country and region, which can make it difficult for companies to navigate the approval process. In addition, the regulatory landscape is constantly evolving, which can create uncertainty and delay the launch of new products. The approval process for electric skin patches can be time-consuming and expensive. Companies must invest significant resources in clinical trials and other studies to demonstrate the safety and efficacy of their products. This can be a barrier to entry for smaller companies and startups, which may not have the resources to navigate the regulatory process. • Reimbursement and Pricing Issues: The market is reimbursement and pricing issues. Electric skin patches are often more expensive than traditional treatment options, which can make them less accessible to patients. Insurance coverage for electric skin patches varies by country and region. In some cases, electric skin patches may not be covered by insurance, which can limit their adoption and use. The pricing of electric skin patches can be a challenge for companies. Pricing must be competitive enough to attract customers, but also high enough to cover the costs of development, manufacturing, and marketing. Finding the right balance can be difficult, especially in a rapidly evolving market.

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now

Based on the report, the Application Segment is segmented into Diabetes Management, Cardiovascular, Patient Monitoring and Others. Diabetes management is leading in the electric skin patch industry due to the high prevalence of diabetes globally and the critical need for continuous and non-invasive glucose monitoring, which electric skin patches can efficiently provide. Diabetes, a chronic condition characterized by high blood sugar levels, affects millions of people worldwide. Managing this condition requires regular monitoring of blood glucose levels to prevent complications and ensure optimal health outcomes. Traditional methods for monitoring glucose levels, such as finger-prick blood tests, are invasive, painful, and can be inconvenient for patients, leading to poor compliance and inconsistent monitoring. This is where electric skin patches come into play, offering a revolutionary approach to diabetes management. Electric skin patches for diabetes management, also known as continuous glucose monitors (CGMs), are wearable devices that provide real-time glucose level monitoring without the need for frequent blood draws. These patches are designed to be minimally invasive, attaching to the skin and using tiny sensors to measure glucose levels in the interstitial fluid just beneath the skin. The data collected by these sensors is transmitted wirelessly to a smartphone or a dedicated monitoring device, allowing patients and healthcare providers to track glucose levels continuously and make informed decisions about diet, medication, and lifestyle adjustments. Electric skin patches enhance patient compliance and quality of life. Traditional glucose monitoring methods require multiple daily finger pricks, which can be painful and cumbersome. Many patients find it challenging to adhere to this regimen, leading to infrequent monitoring and suboptimal diabetes management. Electric skin patches, on the other hand, provide a pain-free alternative that encourages more consistent use. The ease of applying the patch, combined with the ability to monitor glucose levels in real-time, empowers patients to take a proactive role in managing their condition. Technological advancements have also played a significant role in propelling the use of electric skin patches for diabetes management. Modern CGMs are equipped with advanced algorithms that provide accurate glucose readings, trend data, and predictive alerts for potential glucose level changes. These features enable patients to take pre-emptive actions to prevent dangerous highs and lows, further improving overall diabetes control. Integration with mobile apps and cloud-based platforms facilitates data sharing with healthcare providers, allowing for remote monitoring and timely interventions. The economic burden of diabetes is another factor driving the demand for electric skin patches. Diabetes is associated with significant healthcare costs, including hospitalizations, medications, and long-term complications. By improving glucose control and reducing the incidence of complications, electric skin patches can contribute to cost savings for both patients and healthcare systems. Health insurers and policymakers recognize the value of these devices, leading to increased coverage and reimbursement, which further encourages their adoption. Based on the report, the Connectivity Segment is distinguished into Connected Patch and Disconnected Patch. The main reason why connected patches are growing in the electric skin patch industry is due to the increasing demand for remote patient monitoring and the need for real-time data to improve patient outcomes. The growth of connected patches in the electric skin patch industry is driven by several factors. First, there is a growing demand for remote patient monitoring as a way to improve patient outcomes and reduce healthcare costs. Remote patient monitoring allows healthcare providers to monitor patients outside of traditional clinical settings, such as hospitals and clinics. This can help to identify potential health issues before they become serious and reduce the need for hospitalizations and emergency room visits. Connected patches, also known as smart patches, are electric skin patches that use wireless connectivity to transmit data to a remote monitoring system. These patches can monitor a variety of physiological parameters, such as heart rate, temperature, and glucose levels, and transmit the data to healthcare providers or caregivers in real-time. Connected patches offer a non-invasive and convenient way to monitor patients remotely. Patients can wear the patch on their skin and go about their daily activities while the patch collects data. The data can be transmitted wirelessly to a remote monitoring system, allowing healthcare providers to monitor patients in real-time. This can improve patient outcomes by enabling early intervention and reducing the need for hospitalizations. There is a growing need for real-time data to improve patient outcomes. Connected patches can provide real-time data on a variety of physiological parameters, allowing healthcare providers to make informed decisions about patient care. For example, a connected patch that monitors glucose levels can alert healthcare providers to changes in blood sugar levels, allowing them to adjust medication dosages or make other changes to the treatment regimen. Connected patches can also improve medication adherence. Patients can receive reminders to take their medication through the patch, and healthcare providers can monitor medication adherence through the data collected by the patch. This can improve patient outcomes by ensuring that patients are taking their medication as prescribed. Several companies are developing connected patches for various applications. For example, Abbott has developed the Freestyler Libre system, which uses a connected patch to monitor glucose levels continuously for up to 14 days. Similarly, VitalConnect has developed the VitalPatch, which uses a connected patch to monitor a variety of physiological parameters, including heart rate, temperature, and respiratory rate. The main reason why North America is leading in the electric skin patch industry is due to the presence of a well-established healthcare system, high healthcare spending, and a large patient population with chronic diseases. North America, particularly the United States, has a well-established healthcare system with advanced medical infrastructure and technology. This provides a favorable environment for the adoption of innovative medical devices, including electric skin patches. The presence of a large number of healthcare providers and payers, such as hospitals, clinics, and insurance companies, also contributes to the growth of the electric skin patch market in North America. North America has a high level of healthcare spending, which is expected to continue to grow in the coming years. North America has a large patient population with chronic diseases, such as diabetes, cardiovascular disease, and respiratory disorders. These diseases require long-term management and monitoring, which can be facilitated by electric skin patches. electric skin patches can be used to monitor glucose levels in patients with diabetes or to deliver medication to patients with cardiovascular disease. The growing prevalence of chronic diseases in North America is expected to drive the demand for electric skin patches in the coming years. North America is home to several key players in the electric skin patch market, such as Abbott Laboratories, Medtronic, and Johnson & Johnson. These companies are investing in research and development to develop innovative electric skin patches for various applications. Medtronic has developed the Guardian Connect system, which uses a connected patch to monitor glucose levels and provide predictive alerts to patients with diabetes. There are also challenges facing the electric skin patch market in North America. The high cost of electric skin patches may be a barrier to adoption for some patients, particularly those without insurance coverage. In addition, there are regulatory challenges associated with the approval and reimbursement of electric skin patches. Companies must navigate these challenges to ensure the success of their products in the market. Considered in this report • Historic year: 2018 • Base year: 2023 • Estimated year: 2024 • Forecast year: 2029 Aspects covered in this report • Electric Skin Patch market Outlook with its value and forecast along with its segments • Various drivers and challenges • On-going trends and developments • Top profiled companies • Strategic recommendation By Type • Monitoring & Diagnostic • Therapeutic By Components • Stretchable Circuits • Stretchable Conductors • Electro-active Polymers • Photovoltaic • Others By Wireless Connectivity • Connected Patch • Dis connected Patch By Application • Diabetes Management • Cardiovascular • Patient Monitoring • Others End-User • Pharmacies • Online Channel • Others ? The approach of the report: This report consists of a combined approach of primary and secondary research. Initially, secondary research was used to get an understanding of the market and list the companies that are present in it. The secondary research consists of third-party sources such as press releases, annual reports of companies, and government-generated reports and databases. After gathering the data from secondary sources, primary research was conducted by conducting telephone interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this; we have started making primary calls to consumers by equally segmenting them in regional aspects, tier aspects, age group, and gender. Once we have primary data with us, we can start verifying the details obtained from secondary sources. Intended audience This report can be useful to industry consultants, manufacturers, suppliers, associations, and organizations related to the Electric Skin Patch industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing and presentations, it will also increase competitive knowledge about the industry.